Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.Abgent at Your Virtual Science Event Cancer: Research, Discovery & Therapeutics
October 29 - 30, 2014
Online from your Desktop
Abgent, a WuXi AppTec company, is a leading manufacturer of primary antibodies and peptides with fifteen years of experience. We deliver highly-validated antibodies to research and drug discovery clients worldwide.
Visit Abgent booth at the virtual conference - Cancer: Research, Discovery & Therapeutics to chat with our booth rep.
| Fill out the survey at our virtual booth for a chance to win a $50 Amazon Gift Card $50 amazon Gift Card |
 |
Abgent Custom Services:
Abgent is known for its exceptional custom services for research and development in academic and industrials sector.
We offer custom antibody development, antibody validation, custom peptide synthesis, custom protein expression, and custom flow cytometry services.
- 20,000+ antibody projects completed.
- 30,000+ peptides synthesized.
- WB, IHC, IF validations available.
- AAALAC and ISO accredited facility.
Abgent Products:
Abgent antibodies are produced in-house to ensure product quality and reproducibility. We focus on cancer, neurodegeneration, autophagy, and stem cell targets.
- Over 18,000 primary antibodies with 1,000+ new antibodies released per year.
- Featuring the Abgent "Crown" line of premium antibodies.
- Evaluation size vials for more than 10,000 products.
- More than 500 phospho-specific antibodies.
- PREV: Back To The Lab! One Week Left!
- NEXT: Crown Flash 6!
